Disclosures for "Association Between Wearable Sensor Data and Clinical Scores in Individuals with Early-stage Multiple System Atrophy"
-
Dr. Mann has nothing to disclose.
-
Jose Casado has received personal compensation for serving as an employee of Biosensics.
-
Ram Kinker Mishra has received personal compensation for serving as an employee of BioSensics LLC.
-
Adonay Nunes has nothing to disclose.
-
Paula Trujillo Diaz has nothing to disclose.
-
Miss Iregui has nothing to disclose.
-
Ms. Wynn has nothing to disclose.
-
Cynthia Wong has received personal compensation for serving as an employee of Alterity Therapeutics. An immediate family member of Cynthia Wong has received personal compensation for serving as an employee of RefleXion Medical. Cynthia Wong has stock in Teva. An immediate family member of Cynthia Wong has stock in 10x Genomics.
-
Dr. Stamler has received personal compensation for serving as an employee of Alterity Therapeutics. Dr. Stamler has stock in Alterity Therapeutics.
-
Dr. Vaziri has received personal compensation for serving as an employee of Biosensics.
-
Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spark . The institution of Dr. Claassen has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Alterity. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Michigan. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for HD Insights. The institution of Dr. Claassen has received research support from NIH. The institution of Dr. Claassen has received research support from CHDI. The institution of Dr. Claassen has received research support from HDSA. The institution of Dr. Claassen has received research support from Department of Defense. The institution of Dr. Claassen has received research support from CHDI. The institution of Dr. Claassen has received research support from Genentech/ Roche.